Scarica l'app Stockscreener
0.63
3.74%
0.0227
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie
CLASS ACTION DEADLINE TONIGHT MONDAY, MARCH 16: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline Tonight - The Daily Tribune News
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit - Financial Times
Vistagen Therapeutics, Inc. (VTGN) Eyes Breakthrough with Phase 3 Social Anxiety Trial - MSN
VTGN DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. ... - Black Hills Pioneer
VTGN DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important March 16 Deadline in Securities Class Action - GlobeNewswire Inc.
VTGN UPCOMING DEADLINE ON MONDAY, MARCH 16: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit (2026-03-14) - Seeking Alpha
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 16, 2026 in Vistagen LawsuitVTGN - PR Newswire
VTGN DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Vistagen Therapeutics, Inc. Investors ... - Caledonian Record
VTGN DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages - GlobeNewswire
VTGN Shareholder Alert: Vistagen Therapeutics, Inc. - GlobeNewswire
2026-03-13 | VTGN DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Vistagen Therapeutics, Inc. Investors to Join the Class Action Lawsuit Today | NDAQ:VTGN | Press Release - Stockhouse
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesVTGN - Sahm
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - lelezard.com
Holzer & Holzer, LLC Reminds VTGN Investors of the March 16, 2026 Lead Plaintiff Deadline in the Vistagen Therapeutics, Inc. Securities Class Action - marketscreener.com
Holzer & Holzer, LLC Reminds VTGN Investors of the March - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
VTGN INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 - ChartMill
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER - GlobeNewswire
VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 - Lelezard
Vistagen Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsVTGN - cnhinews.com
Layoff Tracker: Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds - BioSpace
Does Vistagen Therapeutics Inc. stock trade at a discount to peersForecast Cut & Reliable Price Action Trade Plans - mfd.ru
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, - GlobeNewswire
Vistagen Therapeutics, Inc. Files Form 8-K with SEC: Company Information, Stock Details, and Compliance Disclosures (March 2026) - Minichart
Aug Highlights: Will Vistagen Therapeutics Inc outperform during market ralliesIPO Watch & Long Hold Capital Preservation Tips - baoquankhu1.vn
Vistagen Therapeutics reduces workforce by 20 percent to manage costs - Investing.com South Africa
LEVI & KORSINSKY, LLP ADVISORY TO INSTITUTIONAL INVESTORS: CLASS ACTION AGAINST VISTAGEN THERAPEUTICS MAY IMPACT PORTFOLIO HOLDINGS - PR Newswire
VistaGen Announces Workforce Reduction to Extend Cash Runway - TipRanks
Vistagen Therapeutics Implements 20% Workforce Reduction - TradingView
Vistagen Therapeutics cuts ~20% of workforce, expects PALISADE-4 topline H1 2026 and cash into 2027 - TradingView
VTGN DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages - GlobeNewswire
VTGN INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026 - marketscreener.com
Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against Vistagen Therapeutics, Inc.(VTGN) - PR Newswire
Portnoy Law Firm Announces Class Action on Behalf of Vistagen Therapeutics, Inc. Investors - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Vistagen Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi ... - Bluefield Daily Telegraph
Vistagen Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Vistagen - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 - TMX Newsfile
VTGN (Vistagen Therapeutics) ROC (Joel Greenblatt) % : -5,196.68% (As of Dec. 2025) - GuruFocus
VTGN DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Vistagen Therapeutics, Inc. ... - Bluefield Daily Telegraph
VTGN DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, - GlobeNewswire
VTGN (Vistagen Therapeutics) EV-to-EBITDA : 0.52 (As of Mar. 07, 2026) - GuruFocus
VTGN (Vistagen Therapeutics) Shareholder Yield % : -128.43% (As of Dec. 2025) - GuruFocus
Vistagen Therapeutics (MEX:VTGN) Accounts Receivable : MXN0.00 Mil (As of Dec. 2025) - GuruFocus
VTGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026 - ACCESS Newswire
Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints - Sahm
Vistagen Therapeutics (MEX:VTGN) Graham Number : MXNN/A (As of Dec. 2025) - GuruFocus
Vistagen Therapeutics (MEX:VTGN) Beginning Cash Position : MXN1,130.51 Mil (As of Dec. 2025) - GuruFocus
Vistagen Therapeutics (MEX:VTGN) Other Income (Minority Int - GuruFocus
Vistagen Therapeutics Inc (MEX:VTGN) DCF Valuation - GuruFocus
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ... - Bluefield Daily Telegraph
2026-03-05 | VTGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:VTGN | Press Release - Stockhouse
Vistagen Therapeutics (MEX:VTGN) Shiller PE Ratio : (As of Mar. 05, 2026) - GuruFocus
VTGN DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
UPCOMING DEADLINE: Vistagen Therapeutics, Inc. (VTGN) Securities Fraud Class ActionMarch 16, 2026 Lead Plaintiff Deadline - Lelezard
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the Firm Regarding the Upcoming March 16th Lead Plaintiff Deadline - marketscreener.com
EBITDA of Vistagen Therapeutics, Inc. – BMV:VTGN - TradingView
Notice of Class Action Lawsuit Against Vistagen Therapeutics - Intellectia AI
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):